Alfonso Valle
@ValleAlfonso · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 75 likes · 31 shares · 21,712 followers
View post →
N Engl J Med November 2022 PMID 36342113
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Mentions
283
Peak: 72 in Nov 2022
across 6 sources since Nov 2022
Extended reach
4,632,540
potential audience
Total likes
7,912
Video views
305,475
Mentions per month
Nov 2022 – Jul 2025Where it's discussed
-
X / Twitter186 posts
-
News76 articles
-
Blogs9 articles
-
Facebook5 posts
-
YouTube4 videos
-
Reddit3 posts
AI synopsis
What people are saying
Discussions reveal a range of reactions focusing on the study's implications, with many users pointing out that while triglycerides were lowered, this did not translate to a decrease in cardiovascular events. Posts like 'lowering triglycerides doesn't do anything for CVD' and comments on the 'disappointment' over the results reflect a critical tone. The language used, such as 'no benefit' and 'failed to meet primary endpoints,' highlights the authors' concerns and frustration with the findings, contributing to an overall skeptical sentiment.
AgreementLow agreement
Many posts express skepticism about the effectiveness of pemafibrate in reducing cardiovascular events, indicating a notable level of disagreement with its anticipated benefits.
InterestHigh interest
There is a high level of curiosity regarding the findings of the publication, as users actively discuss its implications and question its outcomes.
EngagementModerate engagement
While several users express interest and pose questions about the study, the depth of engagement remains moderate with less extensive analysis of the research content.
ImpactLow impact
Contributors perceive the overall impact of the study as limited since it did not yield the expected benefits in cardiovascular risk reduction.
Abstract in brief
- High triglyceride levels increase cardiovascular risk, and pemafibrate is a drug that reduces these levels and improves other lipids.
- In a trial involving nearly 10,500 patients with type 2 diabetes and high triglycerides, participants were randomly assigned to either receive pemafibrate or a placebo.
- After 3.4 years, while pemafibrate significantly lowered triglycerides and other lipid measures, it didn’t show a meaningful difference in reducing serious cardiovascular events compared to placebo, suggesting more research is needed.
Top posts
Most liked on X and BlueskyNEJM
@NEJM · X
This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX0 #cardiology https://t.co/v6nY0m7dPm
May 27, 2023 · 70 likes · 17 shares · 935,782 followers
View post →
Lorenzo Fácila
@mi_cardiologo · X
Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! https://t.co/Zm3nslZPoM https://t.co/jy9kHSUv3z
May 27, 2023 · 61 likes · 23 shares · 7,939 followers
View post →
Dr Sudhir Kumar MD DM
@hyderabaddoctor · X
5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patients who took pemafibrate or placebo. Moreover, pemafibrate caused more renal adverse effects and venous thromboembolism. Ref: https://t.co/nb5Coo6Vq1
Mar 31, 2023 · 32 likes · 6 shares · 96,294 followers
View post →
C. Michael Gibson MD
@CMichaelGibson · X
Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the incidence of cardiovascular events was not lower among those who received pemafibrate than among those who received placebo. https://t.co/MOSTmXeOCk https://t.co/JK8TMAlzuj
May 6, 2023 · 30 likes · 6 shares · 432,064 followers
View post →
Seemant Chaturvedi
@ChaturvediNeuro · X
In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despite 26% reduction in TG and VLDL. 12% increase in LDL observed. Disappointing but icosapent ethyl remains evidence-based option @DLBHATTMD https://t.co/0ZvjRy5Pbw
Nov 27, 2022 · 22 likes · 4 shares · 3,307 followers
View post →
All mentions
Optimizing Low Carb Diets for Heart Health with Dr. Weiss
Low carb doesn't have to increase heart disease risk. Dr. Ethan Weiss, a cardiologist and Prof of Medicine at UCSF, shares expert insights on how to maintain heart health on a low carb diet by focusing on the importance…
Nutrition Made Simple! · Nov 7, 2022
158,294 views
Evaluating Cholesterol Ratios and Lipids in Heart Disease Risk Assessment
Are ratios like triglyceridesHDLC or total cholesterolHDLC reliable measures of heart disease risk? This video discusses the strengths and limitations of cholesterol ratios and explores recent genetic research on…
Nutrition Made Simple! · Jun 5, 2023
145,185 views
Pemafibrate's Impact on Cardiovascular Risk in Diabetes Patients
This video discusses pemafibrate, a drug that lowers high triglyceride levels and improves lipids. A trial with nearly 10,500 patients showed that while it significantly reduced triglycerides, it did not lead to fewer…
Pyroliquid Science · Sep 1, 2024
1,985 views
Triglyceride Lowering Strategies in Cardiovascular Health
High triglyceride levels increase cardiovascular risk. This podcast discusses findings from AHA 2022, focusing on pemafibrate's role in lowering triglycerides and improving lipid profiles, as well as comparing…
Medscape · Mar 27, 2024
12 views
にいやん
@niiyan51 · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/aqh01npRQ2
Jul 26, 2025 · 1,074 followers
View post →
Passionate Davita
@PassionateDavi1 · X
RT @37phoenix: 高中性脂肪血症、低HDLの糖尿病患者へのペマフィブラート(パルモディア)は複合心血管イベントを減少させなった。Pradhan, Aruna Das. N Engl J Med. https://t.co/TAmdXJCUFE
Dec 18, 2024 · 2 shares · 73 followers
View post →
どっぺるさん（お徳用）
@doppel_surg · X
https://t.co/SlptJYsW9p
Oct 16, 2024 · 1 like · 2,730 followers
View post →
Hany Ragy
@Hragy · X
RT @DrDerekConnolly: does lowering triglycerides reduce cardiovascular risk as per the new IAS guidance? the elephant in the room is this…
Aug 21, 2024 · 1 share · 80,434 followers
View post →
Prof Derek Connolly
@DrDerekConnolly · X
does lowering triglycerides reduce cardiovascular risk as per the new IAS guidance? the elephant in the room is this study https://t.co/QHKpck05cw Lets see what result the ANGPTL3 studies produce https://t.co/3WLtngRMY5
Aug 20, 2024 · 5 likes · 1 share · 3,930 followers
View post →
masa 薬剤師
@MasahideOr66774 · X
@penguin_pharm TGは下げるが 心血管イベント減らさない薬って飲む意義あるんだろうか？ https://t.co/fQCddtezyU https://t.co/ctd6XjQsO9
Aug 15, 2024 · 40 followers
View post →
masa 薬剤師
@MasahideOr66774 · X
@Dr_moto_clinic @tbHbXZE9flNNe1W NEJM：DMで低HDL、高TG例には パルモディア効果なしかも!? https://t.co/nPBxAoHd5k
Aug 6, 2024 · 1 like · 40 followers
View post →
りょう@柴犬薬剤師
@notedry_ph · X
RT @Cardio_Pharm_JP: PROMINENT試験 ※96％でスタチン服用にてLDL-C<100 ※ペマフィブラート投与でLDL-C79から91へ上昇したことでTG低下の利益が相殺されているかも…？ https://t.co/IBt10pASlo
Aug 2, 2024 · 1 share · 436 followers
View post →
Dr. Paritosh K Kar
@karpk18 · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | New England Journal of Medicine https://t.co/5CdhKyzLbR
Jun 19, 2024
View post →
fipco
@fipco · X
@BrezanSimonMD @Drlipid @drpablocorral @MohammedAlo @Lipoprotein Based on this observational study, you'd think a big reduction in VLDL-C accompanied by an increase in LDL-C would be beneficial. In the PROMINENT study, pemafibrate did just that and the MACE hazard ratio was 1.03. https://t.co/EVFF7exwsC
Apr 25, 2024 · 233 followers
View post →
Jacob M. Hands
@jacobmhands · X
Pemifibrate fails even though TG, remnant and VLDL decrease! "−26.2% triglycerides, −25.8% very-low-density lipoprotein, −25.6% remnant cholesterol, −27.6% apolipoprotein C-III, and 4.8% for apolipoprotein B" https://t.co/DiuusgHWTO @lipo_fan @Drlipid @JohnKastelein
Apr 4, 2024 · 3 likes · 173 followers
View post →
Prof Derek Connolly
@DrDerekConnolly · X
this is propensity matched registry study not a randomised controlled trial suggesting benefit of fibrates in metabolic syndrome the problem is that in an proper RCT of fibrates v placebo in diabetics with raised triglycerides, there was NO BENEFIT. DOI: 10.1056/NEJMoa2210645 https://t.co/cuxkEUyzLy
Dec 9, 2023 · 6 likes · 3,930 followers
View post →
たけちゃん
@nitrotake · X
PROMINENT試験 これ読んでなかったな。 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/NptB9uranX
Dec 3, 2023 · 1,444 followers
View post →
Pradeep Natarajan
@pnatarajanmd · X
@doctorveera Recent cardiovascular example: pemafibrate (PROMINENT) 4/22 press release https://t.co/OvK6zDvGBA 11/22 trial publication https://t.co/ciSX2W6Uv9
Nov 26, 2023 · 5 likes · 25,371 followers
View post →
循環器病薬剤師ネットワーク(#循薬ネット)
@Cardio_Pharm_JP · X
PROMINENT試験 ※96％でスタチン服用にてLDL-C<100 ※ペマフィブラート投与でLDL-C79から91へ上昇したことでTG低下の利益が相殺されているかも…？ https://t.co/IBt10pASlo
Oct 25, 2023 · 8 likes · 1 share · 4,406 followers
View post →
Science Collected
@ScienceCollect1 · X
17/ #Fibrates reduce TG levels but their impact on #CV outcomes is less clear. The PROMINENT study of pemafibrate was stopped early due to failure to meet the primary endpoint.
Oct 24, 2023 · 124 followers
View post →
ゆるり
@yuruyururururi · X
RT @MR02160602: パルモディア、厳しいなぁ
Oct 16, 2023 · 8 shares · 68 followers
View post →
1型の人生
@osmobox · X
あと、フィブラートは慎重に。フィブラートにはTG低下のエビデンスはあるが予後に影響しないか悪化の可能性もある。まずはnon-HDLを見て、それを下げる目的にスタチンを使う。>1000や脂質関連膵炎ならフィブラート使う。 上記ガイドラインおよび、 https://t.co/RSqftG0ihP
Sep 29, 2023 · 313 followers
View post →
DEENK Library
@deenklibrary · X
Check out this highly cited OA paper titled Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk in The New England Journal of Medicine: https://t.co/wPTy8J1RV0… https://t.co/kMlJvBWcfF… #OpenAccess @DEgyetem @deenklibrary
Sep 15, 2023 · 91 followers
View post →
血中半減期
@wildcard1610 · X
RT @ph_minimal: ペマフィブラートはどうなのか知りたい人はこちらの56ページをみてください https://t.co/K5fN2LyVQs
Sep 8, 2023 · 1 share · 1,259 followers
View post →
みに丸
@ph_minimal · X
ペマフィブラートはどうなのか知りたい人はこちらの56ページをみてください https://t.co/K5fN2LyVQs https://t.co/KqGD3baXXh
Sep 7, 2023 · 6 likes · 1 share · 899 followers
View post →
LogicalⓋegan
@logical__vegan · X
@SteakAndWeights @cactusapinyona @SBakerMD Lowering LDL-c decreases CVD based on the trial I sent. Lowering triglycerides doesn’t do anything for CVD. https://t.co/kVhMWoSpAc https://t.co/IrbJ9sTNMF
Aug 29, 2023 · 1 like · 63 followers
View post →
Dr Ramdas Pananthattil
@PananthattilR · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
Jun 17, 2023 · 17 shares · 793 followers
View post →
Dr Ramdas Pananthattil
@PananthattilR · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 17, 2023 · 6 shares · 793 followers
View post →
Antentor Othrell Hinton, Jr PhD (A.J. Hinton)
@phdgprotein86 · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 5, 2023 · 6 shares · 5,191 followers
View post →
СГАМ
@CGAM2016 · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 3, 2023 · 6 shares · 235 followers
View post →
โต๊ะอุ่น
@kotatsudream · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 3, 2023 · 6 shares · 72 followers
View post →
Andreas Nicko, M.D.
@AndreasNicko4 · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 3, 2023 · 6 shares · 2,091 followers
View post →
Pub Health Monitor
@monitor_PH · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
Jun 3, 2023 · 6 shares · 1,825 followers
View post →
NEJM
@NEJM · X
This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.co/bNtIAwWTX0 #cardiology View all trending articles: https://t.co/ORZDa6ntRn https://t.co/XfGM78RtZq
Jun 3, 2023 · 20 likes · 6 shares · 935,782 followers
View post →
Neurosurgeon뇌혈관
@YounggyunJ · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
Jun 1, 2023 · 17 shares · 162 followers
View post →
Nest
@nest_kc · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 31, 2023 · 17 shares · 56 followers
View post →
Min Seo Kim, MD, MSDH
@MinSeoKim_MD · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 29, 2023 · 17 shares · 2,585 followers
View post →
Lorenzo Fácila
@mi_cardiologo · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 7,939 followers
View post →
Dicky Yulianda
@dickyyulianda · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 28, 2023 · 17 shares · 248 followers
View post →
Josep Lluis Melero Ferrer
@dr_melero · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 45 followers
View post →
Seba GZ, MD, MSc
@sebagz1 · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 1,635 followers
View post →
Maite Santamarta
@MaiSanLo · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 408 followers
View post →
rafavidalperez
@rafavidalperez · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 13,838 followers
View post →
Cardio-Primària
@catcardiocamfic · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 1,871 followers
View post →
Carles Falces
@CarlesFalces · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 2,690 followers
View post →
Ana Calber
@amcalber · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 2,281 followers
View post →
ViConejero
@ViConejero · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 1,127 followers
View post →
Ana Cris
@AnaCrisA_R · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 579 followers
View post →
Martin Grübler
@GrublerMartin · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 28, 2023 · 17 shares · 70 followers
View post →
Jorge Minguet
@Jorge_Minguet · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 144 followers
View post →
Alejandro I. Pérez Cabeza
@alejandroipc2 · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 28, 2023 · 23 shares · 1,164 followers
View post →
平社員
@T462759 · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 273 followers
View post →
fabio rodriguez
@FabioDRodriguez · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 82 followers
View post →
@Heart_Team
@Heart_Team1 · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 450 followers
View post →
Dr. Fernando Barreiro
@BarreiroDr · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 3,338 followers
View post →
Ed Márquez
@dremarquezr · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 2,851 followers
View post →
José Mª Gª Quintana
@jose_g_quintana · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 841 followers
View post →
HUGO COLOMBO MD
@HCOLOMBO1958 · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 1,123 followers
View post →
fausto heredia z.
@drfherediaz · X
RT @mi_cardiologo: Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! http…
May 27, 2023 · 23 shares · 4,357 followers
View post →
Lorenzo Fácila
@mi_cardiologo · X
Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! https://t.co/Zm3nslZPoM https://t.co/jy9kHSUv3z
May 27, 2023 · 61 likes · 23 shares · 7,939 followers
View post →
NEJM Journal Watch
@JWatch · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 62,280 followers
View post →
Jaroslav Novotný
@novotnyjarosl · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 605 followers
View post →
Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE
@TomVargheseJr · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 25,786 followers
View post →
Ezeonufo Chukwunonso
@Ezeonufo · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 1,362 followers
View post →
Dr Davenport
@DrCDav · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 570 followers
View post →
romeofiji
@romeofiji · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 7,031 followers
View post →
Samuel Hume
@DrSamuelBHume · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 29,000 followers
View post →
Pub Health Monitor
@monitor_PH · X
RT @NEJM: This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX…
May 27, 2023 · 17 shares · 1,825 followers
View post →
NEJM
@NEJM · X
This week’s most cited articles: 1. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bNtIAwWTX0 #cardiology https://t.co/v6nY0m7dPm
May 27, 2023 · 70 likes · 17 shares · 935,782 followers
View post →
Dr Ramdas Pananthattil
@PananthattilR · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 14, 2023 · 9 shares · 793 followers
View post →
HealthyBuilds
@HealthyBuilds · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/gUepfhH0Ia
May 12, 2023 · 199 followers
View post →
PcMEDProject
@PcMEDProject · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 8, 2023 · 9 shares · 147 followers
View post →
Roshan Bista, MD
@RoshanBista85 · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 7, 2023 · 6 shares · 615 followers
View post →
AntiMachineGunDeathInMassMurderistan = 2025ProLife
@deepvard · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 1,773 followers
View post →
Dr Raul Hera Jimenez
@rhj_74 · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 6, 2023 · 6 shares · 701 followers
View post →
Francisca Martínez
@famartinez2001 · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 6, 2023 · 6 shares · 10,008 followers
View post →
Hany Ragy
@Hragy · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 6, 2023 · 6 shares · 80,434 followers
View post →
andres
@palacioendocrin · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 346 followers
View post →
Dr. Luiz Silva
@DrLuizSilva1 · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 6, 2023 · 6 shares · 390 followers
View post →
Juan Carlos Obaya
@jcobaya69 · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 857 followers
View post →
Juan Carlos Obaya
@jcobaya69 · X
RT @CMichaelGibson: Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the…
May 6, 2023 · 6 shares · 857 followers
View post →
David Peñalver
@drdavidpenalver · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 479 followers
View post →
Min Seo Kim, MD, MSDH
@MinSeoKim_MD · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 2,585 followers
View post →
C. Michael Gibson MD
@CMichaelGibson · X
Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the incidence of cardiovascular events was not lower among those who received pemafibrate than among those who received placebo. https://t.co/MOSTmXeOCk https://t.co/JK8TMAlzuj
May 6, 2023 · 30 likes · 6 shares · 432,064 followers
View post →
Pub Health Monitor
@monitor_PH · X
RT @NEJM: This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.…
May 6, 2023 · 9 shares · 1,825 followers
View post →
NEJM
@NEJM · X
This week’s most cited article: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (PROMINENT trial) https://t.co/bNtIAwWTX0 #cardiology View all trending articles: https://t.co/ORZDa6ntRn https://t.co/j1pQF0hkvg
May 6, 2023 · 21 likes · 9 shares · 935,782 followers
View post →
Hematology & Thromboembolic Diseases
@Hematology123 · X
Triglyceride Lowering with Pemafibrate to Reduce #Cardiovascular Risk For More: https://t.co/vqDE02SEeE
May 4, 2023 · 297 followers
View post →
Dr Peter Bagshaw
@DrPeterBagshaw · X
Fascinating: this drug lowered triglycerides but NOT CVS events (against expectations) The explanation may be that high triglycerides are a marker of other risk factors (e.g. metabolic syndrome) but not causal Association is not causation! https://t.co/Goii3JKiGq
Apr 24, 2023 · 3 likes · 2,431 followers
View post →
joe Godlisten
@jlisten2 · X
RT @hyderabaddoctor: 5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patient…
Mar 31, 2023 · 6 shares · 328 followers
View post →
Aqquarian
@Theaqquarian · X
RT @hyderabaddoctor: 5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patient…
Mar 31, 2023 · 6 shares · 44 followers
View post →
Chaitu007
@ChaitanyaD2020 · X
RT @hyderabaddoctor: 5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patient…
Mar 31, 2023 · 6 shares · 1,448 followers
View post →
@Indianfirst
@bhaadmainjao39 · X
RT @hyderabaddoctor: 5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patient…
Mar 31, 2023 · 6 shares · 1,513 followers
View post →
Dr Sudhir Kumar MD DM
@hyderabaddoctor · X
5. The incidence of cardiovascular events-heart attack, stroke or death due to these diseases- was similar in patients who took pemafibrate or placebo. Moreover, pemafibrate caused more renal adverse effects and venous thromboembolism. Ref: https://t.co/nb5Coo6Vq1
Mar 31, 2023 · 32 likes · 6 shares · 96,294 followers
View post →
Eduardo Villarreal
@eduvillarreal · X
RT @microagencia: En un RCT probaron 3 años una droga que baja los triglicéridos. La droga los baja, pero no mejora la incidencia de evento…
Mar 23, 2023 · 1 share · 326 followers
View post →
Juan Microagencia
@microagencia · X
En un RCT probaron 3 años una droga que baja los triglicéridos. La droga los baja, pero no mejora la incidencia de eventos cardiovasculares. Sorpresa, un indicador aislado no predice demasiado. https://t.co/0vU3TcfmrG
Mar 23, 2023 · 5 likes · 1 share · 7,492 followers
View post →
Primary Care Daily Update
@pcpdailyupdate · X
Reference (https://t.co/L3hcCPHN0X)
Feb 22, 2023
View post →
ep
@Ghislaine_Musk · X
@DaleWil39870290 @aricarbins @wcu98 @ifixhearts No benefit of lowering trigs (fibrate trial last year) https://t.co/nHh44HW86i No benefit of raising HDL (multiple trials on CETP inhibitors) https://t.co/bgPBd6OgpW Great benefit of lowering LDL (JUPITER trial) https://t.co/neildyItZ4
Feb 12, 2023 · 1,916 followers
View post →
Dr. Pedro A. Carrillo Moreno
@cardiodocpedro · X
https://t.co/ogUOh5CpB2
Jan 24, 2023 · 2 likes · 4,250 followers
View post →
بندر الصقري
@BandarAlsaqry · X
@A9eelqh @iK2NAN @DrNouraM1 I think the association between triglycerides and CVS events stil a debate question! For example this study on Pemafibrate shown decreased in level of triglycerides but does not decrease CVD events https://t.co/4EjQVotNTD
Jan 21, 2023 · 29,344 followers
View post →
Pablo Corral MD
@drpablocorral · X
@TriglycerideF @mmillermd1 @DLBHATTMD The Good
Jan 16, 2023 · 1 like · 11,244 followers
View post →
kimberly espinoza flores
@kimberl18659059 · X
RT @hbadanig: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/ywRZ1HDqsy
Jan 12, 2023 · 2 shares
View post →
Aguará Guazú
@elchacaldelint1 · X
@lucasllach @golmig - Los triglicéridos son un factor de riesgo secundario. Acaba de terminar un ensayo con un medicamento que los baja y no dio beneficio cardiovascular (1). - Más que el tamaño, lo importante es el número de partículas y la exposición acumulada. 1- https://t.co/EpPd1YnCsg
Jan 7, 2023 · 1 like · 3,054 followers
View post →
May's Financial Options
@MayOptions · X
RT @ChaturvediNeuro: In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despi…
Jan 6, 2023 · 4 shares · 36 followers
View post →
＃鍼灸まず読む本 の編著者×医はき師×MBA＝てらぽん
@drteraponmba · X
【備忘録】PROMINENT試験 高中性脂肪（TG200-499mg/dl）血症 かつHDL-C 40mg/dL未満など。 にペマフィブラート（add on）投与でも、 主要有害心血管イベント（MACE：心筋梗塞＋虚血性脳卒中＋冠動脈の血行再建術施行＋心血管死亡）とプラセボで軍間差、『無し』。 https://t.co/ngnt9IbkGq
Jan 5, 2023 · 3 likes · 1,181 followers
View post →
Enol Sierra | Experto en Diabetes
@enolsierra · X
Los medicamentos para reducir los TRIGLICÉRIDOS, no disminuyen los eventos cardiacos en DIABÉTICOS Estudio PROMINENT https://t.co/sPa40Szc8d #diabetes #trigliceridos https://t.co/5eW2ALdO2l
Jan 1, 2023 · 3 likes · 1 share · 139 followers
View post →
the paper link
@the_paper_link · X
RT @the_paper_link: Trend up+10: Das Pradhan A, ..., Prominent Investigators (N Engl J Med) __Triglyceride Lowering with Pemafibrate to Re…
Dec 26, 2022 · 1 share · 137 followers
View post →
the paper link
@the_paper_link · X
Trend up+10: Das Pradhan A, ..., Prominent Investigators (N Engl J Med) __Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk__ https://t.co/t9sXAbHUzO
Dec 26, 2022 · 1 share · 137 followers
View post →
めがね坊主@ムムムの源さん
@meganebouz · X
コロナになってからやっていなかった社内有志によるEBM形式の消毒会。3年ぶり〜 ↓読んだ論文 N Engl J Med. 2022 Nov 5. doi: 10.1056/NEJMoa2210645. https://t.co/eLlJHkBEpg https://t.co/VKbOfzLGvC
Dec 22, 2022 · 5 likes · 1,093 followers
View post →
✨Lore
@lorexlandia · X
RT @sociedadSEEN:
Dec 22, 2022 · 1 share · 268 followers
View post →
Sociedad SEEN
@sociedadSEEN · X
Dec 22, 2022 · 3 likes · 1 share · 17,135 followers
View post →
ACCP Cardiology PRN
@accpcardprn · X
This edition of #WhatsNewWednesday features the PROMINENT Trial!
Dec 21, 2022 · 9 likes · 9,298 followers
View post →
SID Italia
@Sid_Italia · X
Journal Club SID Un risultato deludente per uno studio “prominente” - A cura di Domenico Tricò https://t.co/IzPy4IW8wu
Dec 21, 2022 · 4 likes · 569 followers
View post →
Daniel G. León
@Danielgoleon · X
Entre los pacientes con DM tipo 2 e hipertrigliciremia, los fibratos no disminuyen los eventos cardiovasculares. https://t.co/0yB9k7JU5H
Dec 18, 2022 · 1,443 followers
View post →
筋肉博士
@muscle_penguin_ · X
(180/347) #論文マラソン ペマフィブラートは心イベントを抑制するか 多国籍、二重盲検、無作為化、対照試験 2 型糖尿病 プラセボコントロール 10,497人を3.4年追跡 イベント発生に違いはなく。ぺマは有害な腎イベントおよびDVTの上昇、NAFLDの低下と関連。 https://t.co/KuWjaqScaY
Dec 17, 2022 · 6 likes · 36,076 followers
View post →
the paper link
@the_paper_link · X
Trend up+10: Das Pradhan A, ..., Prominent Investigators (N Engl J Med) __Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk__ https://t.co/t9sXAbHUzO
Dec 17, 2022 · 137 followers
View post →
備忘録
@RonAsheton2022 · X
RT @toki_wo_koe: やっぱり、これね。イベントは減らさない。DVT増えんだ
Dec 7, 2022 · 2 shares · 51 followers
View post →
DiabetoPitie
@DiabetoPitie · X
In a randomized trial, the incidence of #cardiovascular events was not lower in patients with #diabetes, HTG, and low HDL cholesterol levels who received #pemafibrate (a selective PPARα), although TG, VLDL cholesterol, remnant cholesterol, and Apo C-III ⬇️ https://t.co/SfSgEY8tmi
Dec 7, 2022 · 290 followers
View post →
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol · X
RT @toki_wo_koe: やっぱり、これね。イベントは減らさない。DVT増えんだ
Dec 6, 2022 · 2 shares · 14,688 followers
View post →
ときヲ
@toki_wo_koe · X
やっぱり、これね。イベントは減らさない。DVT増えんだ
Dec 6, 2022 · 17 likes · 2 shares · 2,580 followers
View post →
Charles Cardone
@CharlesCardone · X
RT @ChaturvediNeuro: In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despi…
Nov 29, 2022 · 4 shares · 78 followers
View post →
Jeremy S. Pollock
@bmorecardiology · X
Will this put the Fibrate story "to bed"... i will likely only use this class of medications if TGs > 500 despite EPA..lowering surrogate markers typically not enough! @DLBHATTMD @NEJM https://t.co/S1qm4CGatA
Nov 29, 2022 · 13 likes · 1,620 followers
View post →
Antonio Manteca
@amango30 · X
RT @RevistaMFSamfyc: Bajar los triglicéridos con pemafibrato para reducir el riesgo cardiovascular https://t.co/17c4FN42NR PMID 36342113
Nov 29, 2022 · 1 share · 138 followers
View post →
Mike Everts
@GeoWizz_ · X
RT @ChaturvediNeuro: In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despi…
Nov 28, 2022 · 4 shares · 426 followers
View post →
Litecoinie
@ltcdebit_credit · X
RT @ChaturvediNeuro: In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despi…
Nov 28, 2022 · 4 shares · 182 followers
View post →
Revista MFAndalucia
@RevistaMFSamfyc · X
Bajar los triglicéridos con pemafibrato para reducir el riesgo cardiovascular https://t.co/17c4FN42NR PMID 36342113
Nov 27, 2022 · 2 likes · 1 share · 722 followers
View post →
Seemant Chaturvedi
@ChaturvediNeuro · X
In @nejm study of > 10K pts with diabetes and mean TG level of 271, no benefit seen with pemafibrate vs placebo. Despite 26% reduction in TG and VLDL. 12% increase in LDL observed. Disappointing but icosapent ethyl remains evidence-based option @DLBHATTMD https://t.co/0ZvjRy5Pbw
Nov 27, 2022 · 22 likes · 4 shares · 3,307 followers
View post →
alfred fischer
@alfredfischer17 · X
Eine Studie, die gegen Fibrate spricht. #medizin #kardiologie #triglyceride #stoffwechsel #cholesterin https://t.co/biZeVEnEKN
Nov 27, 2022 · 2 likes · 362 followers
View post →
andres
@palacioendocrin · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/RfQUVDgZvf
Nov 27, 2022 · 2 likes · 346 followers
View post →
Miguel Turégano
@tureyedro · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 27, 2022 · 31 shares · 811 followers
View post →
石丸裕康(Hiroyasu Ishimaru)
@Ishimaru912 · X
2型DM+中性脂肪高値患者へのパルモディア投与(pemafibrate)で心血管イベントに差出ず、とのことです。中性脂肪の取り扱いは悩ましいですが、自分の現状の方針を変える必要はなさそう。 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/yor0FuIGzt
Nov 26, 2022 · 3 likes · 1 share · 1,304 followers
View post →
John H. Randall
@JohnHRandall1 · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/A7rmP67tgL
Nov 26, 2022 · 44 followers
View post →
Kazuki Yoshida
@kaz_yos · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk - PubMed https://t.co/XDGe4okglL “incidence of cardiovascular events was not lower among those who received pemafibrate than among those who received placebo, although… https://t.co/OcP81d9PLV
Nov 26, 2022 · 5,596 followers
View post →
Dr.Amit
@Amit04Ag · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 25, 2022 · 31 shares · 107 followers
View post →
Dr Ashutosh Mishra MD
@Ashutos15050433 · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 25, 2022 · 31 shares · 1,213 followers
View post →
Fra Ian
@caioqualunque · X
RT @DrDanMO: Pemafibrate: More potent than fenofibrate, and just as useless for reducing CV events. Triglyceride Lowering with Pemafibrate…
Nov 25, 2022 · 2 shares · 2,080 followers
View post →
May's Financial Options
@MayOptions · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 25, 2022 · 31 shares · 36 followers
View post →
Edoardo Melilli
@EdoardoMelilli · X
RT @DrDanMO: Pemafibrate: More potent than fenofibrate, and just as useless for reducing CV events. Triglyceride Lowering with Pemafibrate…
Nov 25, 2022 · 2 shares · 3,261 followers
View post →
CardiologíaSalud
@CardioValencia · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 25, 2022 · 31 shares · 284 followers
View post →
Nathan Leader
@NathanLeader22 · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 25, 2022 · 31 shares · 88 followers
View post →
Dr. Jose Gabian Fortes
@gabianfortes · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 250 followers
View post →
Daniel Coyne
@DrDanMO · X
Pemafibrate: More potent than fenofibrate, and just as useless for reducing CV events. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/dkKfbuM4DA
Nov 24, 2022 · 15 likes · 2 shares · 3,448 followers
View post →
Carlos Maiorana
@MaioranaCarlos · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 343 followers
View post →
Fernando Moya-Méndez E.
@DrMoyaMendezE · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 122 followers
View post →
Jose Seijas Amigo
@AmigoSeijas · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 350 followers
View post →
Italo Kumamoto
@fikkumamoto · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 8,805 followers
View post →
María Riestra
@MariaRiestra_1 · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 1,316 followers
View post →
Sharona Azriel
@SharonaAzriel · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 1,402 followers
View post →
Nelson murillo
@nemurillob · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 247 followers
View post →
Jair Vázquez
@jairlevogiro · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 270 followers
View post →
John H. Randall
@JohnHRandall1 · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/rptFgJreK9
Nov 24, 2022 · 44 followers
View post →
#HelpYouGetGAINS
@helpYOUgetGAINS · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/pGXSUtHU21
Nov 24, 2022 · 16,885 followers
View post →
Alex Kharlamov MD FESC FACC FEACVI
@drskharlamov · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 1,677 followers
View post →
Fatima Villafañe Sanz
@FatimaVillaf · X
RT @vic_pallares: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM
Nov 24, 2022 · 3 shares · 463 followers
View post →
EOLO MORANDI JR.
@eolojr · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 540 followers
View post →
Viri diana
@viridiana_dlt · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 101 followers
View post →
СГАМ
@CGAM2016 · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 235 followers
View post →
Toshiki Kuno, MD, PhD, FESC, FSCAI
@ToshikiKuno · X
初日のFibrate系のTrialがNegative https://t.co/cZbF4md0O8 であったことから、RESPECT EPAやJELISを踏まえるとStatinを使用してのHTGはEPAがいいとは思います。しかしながらREDUCE ITのPlaceboのMineral oilがhsCRPを増やしてしまったため、懐疑的な部分もあります。 https://t.co/fhPmwQnYZ5
Nov 24, 2022 · 4 likes · 4,260 followers
View post →
paulo alvarez
@rpaulotovar · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 441 followers
View post →
fausto heredia z.
@drfherediaz · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 4,357 followers
View post →
Hugo Ignacio
@HugoFuentesHerm · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 287 followers
View post →
Xavier Castells
@xccastells · X
In patients with type 2 diabetes and mild-to-moderate hypertriglyceridemia, pemafibrate imporved lipid profile but failed at reducing cardiovascular events. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/UrhAg08gLJ
Nov 24, 2022 · 422 followers
View post →
augusto uchida
@augustouchida · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 435 followers
View post →
Radcliffe Cardiology
@radcliffeCARDIO · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 22,786 followers
View post →
د . احمد سمان
@Ahmed43101178 · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 6,361 followers
View post →
Medtorek
@Medtorek · X
RT @vic_pallares: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM
Nov 24, 2022 · 3 shares · 13,848 followers
View post →
Gabino Loor
@GabinoLoor · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 141 followers
View post →
Biblioteca HUBA
@bibliohifc · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/p2mdhDg51k
Nov 24, 2022 · 84 followers
View post →
Philipp Lopatka
@LopatkaPhilipp · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 198 followers
View post →
Sherif
@Sherifdotcom · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 133 followers
View post →
Cher ባንቄ
@tsebank · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 49 followers
View post →
Cristobal Morales
@CristobMorales · X
RT @ValleAlfonso: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 31 shares · 17,052 followers
View post →
Alfonso Valle
@ValleAlfonso · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk #PROMINENT
Nov 24, 2022 · 75 likes · 31 shares · 21,712 followers
View post →
Light-Yagami
@LightYa33625392 · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/bBBr7RRy1r
Nov 24, 2022 · 23 followers
View post →
SEMERGEN | Médicos de AP #SEMERGEN25
@SEMERGENap · X
RT @vic_pallares: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM
Nov 24, 2022 · 3 shares · 33,038 followers
View post →
Vicente Pallares
@vic_pallares · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM
Nov 24, 2022 · 9 likes · 3 shares · 5,424 followers
View post →
朴大昊
@daehop · X
結局中性脂肪は下げるが心筋梗塞などのイベントは減らさない。パルモディア、お前もか。 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/e3ypsrTIpU
Nov 23, 2022 · 227 followers
View post →
ときヲ
@toki_wo_koe · X
RT @pinacol: 【RCT】軽度から中等度の高トリグリセリド血症、HDL-コレステロール≤40mg/dLの2型糖尿病患者へのペマフィブラート投与は、プラセボ投与と比較して、非致死性心筋梗塞、虚血性脳卒中、冠血行再建術、心血管死亡の複合転帰を減少させなかった。 #ペ読 h…
Nov 19, 2022 · 2 shares · 2,580 followers
View post →
Luis Figueroa
@LuisFig1706 · X
JournalWise: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. -> Sadly, no https://t.co/cn4LN6aKm6
Nov 18, 2022 · 45 followers
View post →
Tom
@youareinformed · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/hbTXxdHxrG
Nov 18, 2022 · 3,277 followers
View post →
Satoru Mitsuboshi
@3stars67664378 · X
RT @pinacol: 【RCT】軽度から中等度の高トリグリセリド血症、HDL-コレステロール≤40mg/dLの2型糖尿病患者へのペマフィブラート投与は、プラセボ投与と比較して、非致死性心筋梗塞、虚血性脳卒中、冠血行再建術、心血管死亡の複合転帰を減少させなかった。 #ペ読 h…
Nov 12, 2022 · 2 shares · 1,780 followers
View post →
NP AGARWAL世界一フォローを目指しますAiming best in world.
@np_grwl · X
RT @medical_xpress: Triglyceride-lowering trial neutral for cardiovascular event reduction @brighamwomens @nejm https://t.co/QMw5nLm2wP htt…
Nov 12, 2022 · 3 shares · 1,785 followers
View post →
pinacol
@pinacol · X
【RCT】軽度から中等度の高トリグリセリド血症、HDL-コレステロール≤40mg/dLの2型糖尿病患者へのペマフィブラート投与は、プラセボ投与と比較して、非致死性心筋梗塞、虚血性脳卒中、冠血行再建術、心血管死亡の複合転帰を減少させなかった。 #ペ読 https://t.co/6p1aRNQJLO
Nov 12, 2022 · 6 likes · 2 shares · 1,615 followers
View post →
Luis Zurita G.
@LuisZuritaG · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/tShnDP3VkE
Nov 10, 2022 · 6,426 followers
View post →
Philipp Grätzel von Grätz
@dukla_DE · X
Wie viele klinische Studien mit Fibraten müssen eigentlich noch scheitern, bevor wirklich alle glauben, dass diese Dinger kardiovaskulär nix bringen
Nov 7, 2022 · 1 like · 2,966 followers
View post →
renalRCTs
@renalRCTs · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/sjmzK9TYm0 https://t.co/yR6GuIytJe
Nov 7, 2022 · 39 followers
View post →
Dr Anthony Martin
@AMAinsight · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM https://t.co/ACEMYW9IWh
Nov 7, 2022 · 913 followers
View post →
Medical Xpress
@physorg_health · X
RT @medical_xpress: Triglyceride-lowering trial neutral for cardiovascular event reduction @brighamwomens @nejm https://t.co/QMw5nLm2wP htt…
Nov 7, 2022 · 3 shares · 7,100 followers
View post →
Medical Xpress
@medical_xpress · X
Triglyceride-lowering trial neutral for cardiovascular event reduction @brighamwomens @nejm https://t.co/QMw5nLm2wP https://t.co/KJsOfQHBZs
Nov 7, 2022 · 3 likes · 3 shares · 173,074 followers
View post →
Bhopender Thakur
@TheBhupiThakur · X
RT @nick_krontiris: Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/BwQN84HvLC #MetabolicSyndrome #Di…
Nov 6, 2022 · 1 share · 1,367 followers
View post →
Nick Krontiris
@nick_krontiris · X
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk https://t.co/BwQN84HvLC #MetabolicSyndrome #Diabetes #Cholesterol #Triglycerides #InsulinResistance
Nov 6, 2022 · 2 likes · 1 share · 19,032 followers
View post →
No mentions from this source yet.